Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Duligotuzumab
Trade Name
Synonyms MEHD7945A
Drug Descriptions

Duligotuzumab (MEHD7945A) is a two-in-one antibody that inhibits both ERBB3 (HER3) and EGFR signaling, resulting in greater efficacy than monospecific HER antibodies against multiple tumor models (PMID: 22014573, PMID: 29506988).

DrugClasses EGFR Antibody 43 HER3 (ERBB3) Antibody 18
CAS Registry Number 1312797-14-0
NCIT ID C116628


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Afatinib + Duligotuzumab Afatinib Duligotuzumab 0 0
Cobimetinib + Duligotuzumab Cobimetinib Duligotuzumab 0 1
Duligotuzumab Duligotuzumab 0 2
Duligotuzumab + Radiotherapy Duligotuzumab Radiotherapy 0 0

Additional content available in CKB BOOST